Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19
- PMID: 32439095
- PMCID: PMC7234783
- DOI: 10.1016/j.cardfail.2020.04.013
Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19
Similar articles
-
Use of Renin-Angiotensin System Blockers During the COVID-19 Pandemic: Early Guidance and Evolving Evidence.Can J Cardiol. 2020 Aug;36(8):1180-1182. doi: 10.1016/j.cjca.2020.05.033. Epub 2020 Jun 2. Can J Cardiol. 2020. PMID: 32502522 Free PMC article. No abstract available.
-
Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System: JACC Review Topic of the Week.J Am Coll Cardiol. 2020 Jun 23;75(24):3085-3095. doi: 10.1016/j.jacc.2020.04.028. Epub 2020 Apr 16. J Am Coll Cardiol. 2020. PMID: 32305401 Free PMC article. Review.
-
Correlation between renin-angiotensin system and Severe Acute Respiratory Syndrome Coronavirus 2 infection: What do we know?Eur J Pharmacol. 2020 Sep 15;883:173373. doi: 10.1016/j.ejphar.2020.173373. Epub 2020 Jul 15. Eur J Pharmacol. 2020. PMID: 32679185 Free PMC article.
-
COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure.mBio. 2020 May 22;11(3):e00946-20. doi: 10.1128/mBio.00946-20. mBio. 2020. PMID: 32444383 Free PMC article. No abstract available.
-
Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities.Pharmacol Ther. 2020 Nov;215:107628. doi: 10.1016/j.pharmthera.2020.107628. Epub 2020 Jul 9. Pharmacol Ther. 2020. PMID: 32653530 Free PMC article. Review.
Cited by
-
Atypical Complications during the Course of COVID-19: A Comprehensive Review.Medicina (Kaunas). 2024 Jan 15;60(1):164. doi: 10.3390/medicina60010164. Medicina (Kaunas). 2024. PMID: 38256424 Free PMC article. Review.
-
Coronavirus disease 2019 and cardiovascular disease.Tzu Chi Med J. 2023 Jun 13;35(3):213-220. doi: 10.4103/tcmj.tcmj_219_22. eCollection 2023 Jul-Sep. Tzu Chi Med J. 2023. PMID: 37545802 Free PMC article.
-
Acute and Post-Acute COVID-19 Cardiovascular Complications: A Comprehensive Review.Cardiovasc Drugs Ther. 2023 May 20:1-16. doi: 10.1007/s10557-023-07465-w. Online ahead of print. Cardiovasc Drugs Ther. 2023. PMID: 37209261 Free PMC article. Review.
-
Angiotensin-Converting Enzyme 2 Expression and Severity of SARS-CoV-2 Infection.Microorganisms. 2023 Feb 28;11(3):612. doi: 10.3390/microorganisms11030612. Microorganisms. 2023. PMID: 36985188 Free PMC article. Review.
-
Protocol for a 30-day randomised, parallel-group, non-inferiority, controlled trial investigating the effects of discontinuing renin-angiotensin system inhibitors in patients with and without COVID-19: the RASCOVID-19 trial.BMJ Open. 2022 Nov 30;12(11):e062895. doi: 10.1136/bmjopen-2022-062895. BMJ Open. 2022. PMID: 36450422 Free PMC article.
References
-
- Ferrario C.M. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005 May 24;111(20):2605–2610. Epub 2005 May 16. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
